Clinical Trials Browser

Phase 3 × Completed × Breast Diseases × Clear all

NCT04177108 2024-03-27

A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer

Phase 3 Completed

242 enrolled 12 charts

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases, Triple Negative Breast Neoplasms

NCT02422615 2023-11-30

MONALEESA-3

Phase 3 Completed

726 enrolled 17 charts 1 FDA

BreastEndocrine

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Multiple Endocrine Neoplasia Type 1

NCT00039780 2022-07-13

Evaluation of BNP7787 for the Prevention of Neurotoxicity in Metastatic Breast Cancer Patients Receiving Weekly Paclitaxel

Phase 3 Completed

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Paresthesia, Neurotoxicity Syndromes

NCT00887536 2022-04-20

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Phase 3 Completed

Adenocarcinoma, Breast Diseases, Breast Neoplasms, Carcinoma

NCT04718324 2021-05-17

PREMs_PROMs

Phase 3 Completed

Breast Diseases, Breast Neoplasms

NCT01591746 2019-10-10

Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction

Phase 3 Completed

131 enrolled 11 charts

Breast Diseases, Breast Neoplasms, Neoplasms, Pain, Postoperative

NCT00983684 2014-12-05

TARGIT

Phase 3 Completed

Breast Diseases, Breast Neoplasms, Carcinoma, Neoplasms by Site